These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19381118)

  • 1. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD).
    Bellentani S; Marino M
    Ann Hepatol; 2009; 8 Suppl 1():S4-8. PubMed ID: 19381118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
    Vernon G; Baranova A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and diagnosis of NAFLD/NASH.
    Hashimoto E; Taniai M; Tokushige K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
    Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
    Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists.
    Bergqvist CJ; Skoien R; Horsfall L; Clouston AD; Jonsson JR; Powell EE
    Intern Med J; 2013 Mar; 43(3):247-53. PubMed ID: 22646061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of non-alcoholic fatty liver disease.
    Bellentani S; Scaglioni F; Marino M; Bedogni G
    Dig Dis; 2010; 28(1):155-61. PubMed ID: 20460905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
    Amarapurkar DN; Hashimoto E; Lesmana LA; Sollano JD; Chen PJ; Goh KL;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):788-93. PubMed ID: 17565631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASH and NASH.
    Scaglioni F; Ciccia S; Marino M; Bedogni G; Bellentani S
    Dig Dis; 2011; 29(2):202-10. PubMed ID: 21734385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-alcoholic fatty liver disease and steatohepatitis].
    Pár G; Horváth G; Pár A
    Orv Hetil; 2013 Jul; 154(29):1124-34. PubMed ID: 23853345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic.
    Roberts KK; Cochet AE; Lamb PB; Brown PJ; Battafarano DF; Brunt EM; Harrison SA
    Aliment Pharmacol Ther; 2015 Feb; 41(3):293-300. PubMed ID: 25521607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and natural history of non-alcoholic steatohepatitis.
    Argo CK; Caldwell SH
    Clin Liver Dis; 2009 Nov; 13(4):511-31. PubMed ID: 19818302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.
    Musso G; Gambino R; Cassader M; Pagano G
    Ann Med; 2011 Dec; 43(8):617-49. PubMed ID: 21039302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and natural history of patients with NAFLD.
    Bhala N; Younes R; Bugianesi E
    Curr Pharm Des; 2013; 19(29):5169-76. PubMed ID: 23394091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and natural history of NAFLD and NASH.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):1-16, vii. PubMed ID: 17544968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.